Expression of glutathione S-transferase M3 in clear cell renal cell carcinoma and its promoter CpG methylation

Academic Journal of Second Military Medical University

Volumn 29, Issue 11, 2008, Pages 1273-1278

  Wu, Qi ^a   Hou, Jian Guo ^a   Du, Wen Bin ^a   Chang, Wen Jun ^b   Zhai, Yu Jia ^b   Lin, Li Ping ^b   Tan, Xiao Jie ^b   Cao, Guang Wen ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Glutathione transferase; Kidney neoplasms; Neoplasm metastasis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; GLUTATHIONE TRANSFERASE M3;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CULTURE MEDIUM; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; METASTASIS; METASTASIS POTENTIAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 57049165519     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2008.01273     Document Type: Article

References (23)

1. McLaughlin J K, Lipworth L, Tarone R E. Epidemiologic aspects of renal cell carcinoma[J]. Semin Oncol, 2006,33:527-533.
2. Störkel S, Eble J N, Adlakha K, Amin M, Blute M L, Bostwick D G, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) [J]. Cancer, 1997,80:987-989.
3. Jungwirth A, Schally A V, Pinski J, Groot K, Armatis P, Halmos G. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma [J]. Proc Natl Acad Sci USA,1997,94:5810-5813.
4. Chinese source.
5. Chinese source.
6. Tan X, Zhai Y, Chang W, Hou J, He S, Lin L, et al. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma [J]. Int J Cancer,2008,123:1080-1088.
7. Ladero J M, Martínez C, Fernández J M, Martín F, García-Martín E, Ropero P, et al. Glutathione S-transferases pi 1, alpha 1 and M3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans [J]. Pharmacogenomics, 2007, 8: 895-899.
8. Sikdar N, Paul R R, Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers[J]. Int J Cancer, 2004, 109: 95-101.
9. Chinese source.
10. Tollefsbol T O. Epigenetics protocols[M]//Liu L, Wylie R C, HansenN J, Andrews L G, Tollefsbol T O. Profiling DNA methylation by bisulfite genomic sequencing: problems and solutions. New York: Humana Press, 2004:169-179.
11. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes[J]. J Mol Biol,1987,196:261-282.
12. http://cpgislands.usc.edu [2007-09-04]
13. http://www.urogene.org/methprimer/index1.html[2007-09-14]
14. Li L C, Dahiya R. MethPrimer: designing primers for methylation PCRs[J]. Bioinformatics, 2002,18:1427-1431.
15. Medeiros R, Vasconcelos A, Costa S, Pinto D, Ferreira P, Lobo F, et al. Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms[J]. Prostate,2004,58:414-420.
16. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer[J]. Nat Genet,2003,33(Suppl):238-244.
17. Nakayama M, Gonzalgo M L, Yegnasubramanian S, Lin X, De Marzo A M, Nelson W G. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer[J]. J Cell Biochem, 2004,91:540-552.
18. http://string.embl.de[2007-12-25]
19. Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia[J]. Blood,2007,109:52-57.
20. To K K, Zhan Z, Bates S E. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma[J]. Mol Cell Biol,2006, 26:8572-8585.
21. Palmisano W A, Divine K K, Saccomanno G, Gilliland F D, Baylin S B, Herman J G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum [J]. Cancer Res, 2000,60:5954-5958.
22. Zhang Q, Ying J, Zhang K, Li H, Ng K M, Zhao Y, et al. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma [J]. Cancer Lett,2007,249:220-226.
23. Dulaimi E, Ibanez de Caceres I, Uzzo R G, Al-Saleem T, Greenberg R E, Polascik T J, et al. Promoter hypermethylation profile of kidney cancer[J]. Clin Cancer Res,2004,10(12 Pt 1): 3972-3979.